Nipah virus in wastewater: promising for early warning?

Nipah virus (NiV) surveillance remains largely clinical and reactive, meaning outbreaks are often recognised only after severely ill patients reach hospitals. A new review asks whether wastewater-based surveillance could provide earlier warning.

NiV is a high-consequence zoonotic virus with reported case-fatality ratios of 40–75% and documented human-to-human transmission, including in healthcare settings. Fruit bats of the Pteropus genus are the natural reservoir. Pigs can act as amplifying hosts, while horses, dogs, cats, goats and cattle appear to be incidental or spillover hosts.

Current surveillance detects outbreaks late

In endemic countries, surveillance depends mainly on patients presenting with encephalitis or severe respiratory illness. By that stage, transmission to relatives, healthcare workers and other contacts may already have occurred. The problem is especially clear in healthcare settings. The review notes that in Bangladesh, 82 of 248 human cases in one major series resulted from human-to-human transmission. As of June 2026, the authors report at least 764 confirmed clinical cases worldwide and 442 deaths. New cases were still occurring in 2026 in India and Bangladesh.

Why wastewater surveillance is biologically plausible

NiV RNA has been detected in human urine and respiratory secretions, providing plausible routes into hospital wastewater. In contrast, human faecal shedding has not been confirmed, which weakens the case for community-wide sewage surveillance. For that reason, the authors consider urine-rich hospital wastewater a more realistic first target than municipal sewage. Animal wastewater may also be relevant because infected pigs shed virus through urine, respiratory secretions and faeces.

Major technical gaps remain

The main problem is that NiV has never been systematically studied in wastewater. Researchers do not yet know how long viral RNA persists, whether it binds preferentially to solids or remains in the liquid phase, or how efficiently it can be recovered from sewage. Molecular detection is another limitation. RT-qPCR is the reference method, but the review notes that relatively few independent, open-source NiV assays are available and validated for environmental samples.

BSL-4 requirements complicate implementation

NiV is a BSL-4 pathogen, creating major practical constraints for handling untreated wastewater potentially containing infectious virus.

The authors suggest that validated chemical or thermal inactivation could allow downstream RNA extraction and PCR testing at lower containment, but initial sample handling would still require strict biosafety procedures and probably limit testing to specialised reference laboratories.

The review therefore proposes pilot studies rather than immediate deployment: first characterise shedding, test NiV RNA recovery in representative wastewater, validate open-source RT-qPCR or digital PCR assays, and focus initial surveillance on hospitals treating suspected cases and selected high-risk animal settings.

So,t wastewater surveillance for Nipah virus is biologically credible but not yet technically or operationally demonstrated. For now, it should be viewed as a potential complement to clinical, animal and environmental One Health surveillance rather than a ready-to-use early-warning system.